Ibrahim Halil SAHIN, MD really important insights!!! thank you. posted!

What an honor and privilege to serve President Biden and the American people working to improve health outcomes for everyone in this country.

Guardant Shield is now FDA approved as a blood test for CRC screening.

✳️ Our research article on molecular underpinnings of young onset CRC is now accepted for a publication ‼️ ✳️More to come on this interesting article ‼️ CRC Change Manju George MVSc PhD Rectal Cancer Survivor #CRCTrialsChat Deniz Can Guven

So well deserved Smitha Krishnamurthi ‼️ Congratulations ‼️

Eileen M. O'Reilly, MD, details how RAS-directed therapy could potentially change the pancreatic cancer landscape and highlights updated data in the space. Eileen M O’Reilly Memorial Sloan Kettering Cancer Center #pancsm #oncology onclive.com/view/ras-direc…

What happens when easy-to-repair nicks in a DNA molecule are converted into potentially catastrophic double-strand breaks during the process of DNA replication? Scientists at NCI Center for Cancer Research answer this question in a new study: go.nih.gov/np5D0EE

✳️I was thrilled to give a talk on my clinic trials (NCT06365970, NCT06006923) in which we aim to optimize tumor microenvironment and enhance antitumor immune response #IOsummit Cambridge Healthtech Institute ‼️ ✳️We will be conducting several correlative analysis once studies are completed to

Surgeons are curing cancer and extending lives. President Biden & Jill Biden delivering on their commitment to end cancer as we know it. Announcing $150M from ARPA-H to improve tumor-removal surgeries #BidenCancerMoonshot

The Trial Finder at Fight Colorectal Cancer is now curating trials for MSI patients. 46 trials immunotherapy focused trials for MSI patients - 31 trials allow prior immunotherapy Let's find a way for more response to /O in MSI mCRC patients! Ibrahim Halil SAHIN, MD fightcolorectalcancer.org/trial-results/…

Ibrahim Halil SAHIN, MD Cambridge Healthtech Institute Here's the post from Fight Colorectal Cancer Trial Finder fightcolorectalcancer.org/clinical-trial… Helpful Links - useful for pts/oncologists thelancet.com/journals/eclin… @SassyCell -I/O directed?

From an 8% chance of surviving 5 years to celebrating TEN YEARS of beating down stage IV #coloncancer 💪 Take THAT cancer!!! 👊 BTW- my shirt says “Badass” 🙌 #grateful #thankful #blessed #cancerfree #thriver

Today is the Pittsburgh Annual Oncology Symposium! An opportunity to enhance your expertise in oncology with UPMC experts leading the way. #Education #UPMC #Fellowship

It was an amazing & a very rewarding day 🤩💫 we are immensely grateful to our sponsors, speakers, colleagues, research partners, mentors, mentees, & supporters! ✨✨✨✨ UPMC Physician Resources UPMC Hillman Cancer Center University of Pittsburgh John Rhee

I will always remember you, Jennell… and your beautiful smile … (With the courtesy and permission of Mr Benford)

Hope to see you TONIGHT at 7pm EDT to hear from Dr. Fong on mCRC liver mets! 💙 Zoom info below. ⬇️💙 COLONTOWN #crcsm

We highlight the important role of tissue resident memory T cells in response to neoadjuvant IO and implication of their surgical removal !! @asco; @aacr; @aga; Mayo Clinic Comprehensive Cancer Center; Mayo Clinic

Our new article is out Scientific Reports 📢📢 We evaluated the WNT and TGF-B alterations in Young-Onset CRC ‼️ ☑️Similar rate of mutations in the WNT pathway ↔️↔️ ☑️Lower rate of mutations in the TGF-B pathway in the Young-Onset CRC ⬇️⬇️ ☑️Higher median TMB in Young-Onset CRC⬆️⬆️